Barbados vs Sri Lanka: Cause of death, by non-communicable diseases, ages 5-14, female
Barbados
45.8%
in 2021
Sri Lanka
45.9%
in 2021
Barbados rank
73rd
Sri Lanka rank
72nd
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Barbados
- Sri Lanka
How they compare
Sri Lanka currently reports 45.9% against 45.8% in Barbados, a difference of 0.1%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Barbados ahead.
Barbados ranks 73rd and Sri Lanka ranks 72nd of 184 countries.
Barbados has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Barbados | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 48.8% | 44.1% | 4.7% | Barbados |
| 2010s | 48.0% | 39.0% | 8.9% | Barbados |
| 2020s | 48.2% | 47.7% | 0.5% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Barbados or Sri Lanka?
- Sri Lanka, at 45.9% against 45.8% in Barbados as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Barbados and Sri Lanka?
- 0.1%, with Sri Lanka ahead.
- How many years of comparable data are there for Barbados and Sri Lanka?
- 6 years are reported by both, from 2000 to 2021.
- How do Barbados and Sri Lanka rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Barbados ranks 73rd and Sri Lanka ranks 72nd of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.